Home > Newsletters > FDAnews Drug Daily Bulletin > Thirty-One States Call on SCOTUS to Quash Pay-for-Delay Deals
FDAnews Drug Daily Bulletin
Nov. 27, 2012 | Vol. 9 No. 231
Thirty-One States Call on SCOTUS to Quash Pay-for-Delay Deals
Attorneys general from 31 states have joined the FTC in urging the Supreme Court to review the legality of — and halt — generic and brand-drug makers’ pay-for-delay agreements by overturning an 11th Circuit Court’s decision that upheld the legality of reverse patent settlements. The states said the court should take up the issue to resolve a lower-court split that has spurred industry uncertainty.
International Pharmaceutical Regulatory Monitor
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.